Nationa

Covid-19: The daily dose (June 23, 2021)

PT Jyothi Datt Mumbai | Updated on June 23, 2021

We curate for you all the Covid-19-related developments and stories of the day worth reading

# Day 2 of the revised Covid-19 vaccination programme shows the strain of sustaining the blistering pace of Day 1, and some uncomfortable statistics come out on States like MP, that don’t quite add up.

https://www.thehindubusinessline.com/news/mp-drags-vaccination-numbers-to-5283-lakh-on-tuesday/article34917053.ece?homepage=true

# Vaccination camps, the good, bad and ugly. Good public health outreach, say experts, but watch for the pitfalls.

https://www.thehindubusinessline.com/news/vaccination-camps-some-get-scammed-others-end-up-paying-more/article34916384.ece?homepage=true

# The latest worry for health administrators in India and overseas – Delta-plus.

https://www.thehindubusinessline.com/economy/22-cases-of-delta-plus-variant-in-india/article34914501.ece?homepage=true

# US expert Dr Fauci, says so too.

https://www.thehindubusinessline.com/news/world/delta-variant-greatest-threat-to-us-covid-19-efforts-dr-fauci/article34921004.ece

# Pfizer chief indicates that discussions to bring their vaccine to India are in its final stages.

Can’t find the link.

# AstraZeneca cites Oxford University study to reiterate a statement it had made about a week ago – that their Covid-19 vaccine is effective against the variant first identified in India.

https://www.thehindubusinessline.com/news/national/astrazeneca-vaccine-effective-against-covid-19-variants-identified-in-india/article34920954.ece

# Congress leader Rahul Gandhi releases a white paper on managing Covid-19, as another surge is imminent.

https://www.thehindubusinessline.com/news/national/dont-neglect-opposition-ruled-states-rahul-to-modi/article34900463.ece

Published on June 23, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.